The Pulmonary Fibrosis Foundation (PFF)Â announced that United Therapeutics will sponsor the PFF Registry. The Registry is a…
Articles by Marisa Wexler, MS
A four-year, $2.4 million federal grant given investigators at Boston University School of Medicine (BUSM) will support work to create a…
The Open Source Imaging Consortium (OSIC), a nonprofit collaborative group focused on combatting lung diseases, announced the winners of a…
People with prediabetes or diabetes who live in smog-filled cities may be more prone to pulmonary fibrosis as a result…
The U.S. Food and Drug Administration (FDA) has granted treprostinil orphan drug designation for the treatment of idiopathic pulmonary…
The global COVID-19 pandemic has had a negative local impact on healthcare for most people in the U.K. with…
Newly developed therapies may hold promise for the treatment of pulmonary fibrosis, as described in two studies. The therapies,…
Galapagos and OncoArendi Therapeutics have entered into an exclusive agreement for the global development and commercialization…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…